Bentham Press Release!

Current Molecular Pharmacology indexed in Science Citation Index (SCI) by Clarivate Analytics

 

Clarivate Analytics (formerly Thomson Reuters Intellectual Property & Science business) has selected the Bentham Science journal Current Molecular Pharmacology for coverage in the Science Citation Index (SCI). The Science Citation Index (SCI) is a citation index originally produced by the Institute for Scientific Information (ISI) and is made available online through different platforms, such as the Web of Science and SciSearch.

Current Molecular Pharmacology publishes the latest developments in cellular and molecular pharmacology with a major emphasis on the mechanism of action of novel drugs under development, innovative pharmacological technologies, cell signaling, transduction pathway analysis, genomics, proteomics, and metabonomics applications to drug action.

For more information about the journal, visit: http://benthamscience.com/journals/current-molecular-pharmacology/

Wishing A Very Happy Birthday Dr. Ling Tau Chuan!

happy birthday background

Dr. Ling Tau Chuan

Editor-in-Chief: Current Biochemical Engineering

University of Malaya
Kuala Lumpur
Malaysia

New Issue :: Current Topics in Medicinal Chemistry 17, Issue 11

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to a specific topic, containing six to nine reviews, which provide the reader a comprehensive survey of that area. A Guest Editor who is an expert in the topic under review, will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. The study of how structure and function are related is absolutely essential to understanding the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight, and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important advances.

ctmc

Articles from the journal Current Topics in Medicinal Chemistry 17,  Issue 11:

For details on the articles, please visit this link :: http://bit.ly/2rSwdvy

 

 

Active free trials in the universities around the world!

SCD Universite de Besancon (University of Franche-Comté), France

The University of Franche-Comté is a French university in the Academy of Besançon with five campuses: Besançon (Doubs), Belfort (named for Léon Delarbre), Montbéliard (Doubs), Vesoul (Haute-Saône), and Lons-le-Saunier (Jura). The university was founded in 1423 in Dole, at that time in the Duchy of Burgundy. It was moved to Besançon in 1691 as Dole was being punished for having resisted too long against the king of France Louis XIV during his conquest of the region.

free-trial

Highlighted Article Flyer for the journal “Current Organic Chemistry”

COC-Articles_21-28- Muhammad S. Khan

http://www.eurekaselect.com/node/151782/article/synthesis-and-characterization-of-a-thienopyrazine-based-low-band-gap-polyarylene-ethynylene-and-photocell-studies-of-the-poly-yneperylene-dye-blend-with-broad-photocurrent-spectrum

 

Article by Disease – “Early Palliative Care in Advanced Oncologic and Non-Oncologic Chronic Diseases: A Systematic Review of Literature”

Article by Disease on “Oncology

Graphical Abstract:

 

Abstract:

Background: To assess the role of early palliative care in patients with advanced oncologic and non-oncologic chronic diseases.

Methods: A qualitative systematic review of literature was performed. All the randomized phase III trials comparing early, simultaneous palliative care and standard care in patients with advanced oncologic and non-oncologic diseases were considered eligible and included into the analysis. The outcomes were classified into 6 classes: quality of life, symptoms control, overall survival, quality of care, patients’ and caregivers’ satisfaction, and costs of the assistance.

Results: Twelve papers reporting the data of 9 trials were considered eligible and included into the analysis. Two nonrandomized trials were also included into the selection because of the methods used by the authors. The early, simultaneous approach was reported to improve quality of life in two out of 7 papers, symptoms control in 1 out of 5 papers, overall survival in 2 out of 3 papers, quality of care in 5 out of 8 papers, patients’ or caregivers’ satisfaction in 3 out of 4 papers; and to reduce the costs of assistance in 2 out of 3 papers.

Conclusion: Early palliative care improves the main outcomes of the assistance in patients with advanced oncologic and non-oncologic chronic diseases. The available data are probably enough to consider early palliative cares a novel standard of care in these groups of patients.

Read more: http://www.eurekaselect.com/node/135802/article

New Issue :: Letters in Drug Design & Discovery 14, Issue 4

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

LDDD

Articles from the journal Letters in Drug Design & Discovery 14, Issue 4:

For details on the articles, please visit this link :: http://bit.ly/2rOKR7H

 

 

Highlighted Article Flyer for the journal “CNS & Neurological Disorders – Drug Targets”

CNS-Articles_16-10-Simona Pichini

http://www.eurekaselect.com/151579/article

Thought of the Day!

Whenever you find yourself on the side of the majority, it is time to pause and reflect. - Mark Twain

Editor’s Choice – “The Status of Methicillin Resistance Among Egyptian Staphylococcus aureus Isolates: An Overview”

Journal: Infectious Disorders – Drug Targets

Author(s): Alaa Abouelfetouh

iddt

Abstract:

Methicillin resistant Staphylococcus aureus (MRSA) is responsible for a large number of antibiotic resistant infections worldwide. Understanding the epidemiology and identifying the molecular characteristics of MRSA is elemental in designing infection control plans to minimize the risks associated with these infections. The prevalence of MRSA varies between the different geographic regions. In Egypt, such knowledge is sparse, with a limited number of isolated studies reporting the infection rate of MRSA in select parts of the country. This work summarizes the few published reports that described MRSA prevalence and types in Egypt.

Read more here: http://www.eurekaselect.com/144438/article